| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/13/2002 | US6432397 Upon hydrolysis, releases conjugates of nonpeptidic polymers and biologically active molecules with an amino group; peg and protein conjugates released in vivo; peg has at least one hydrolytically unstable linkage in its backbone, such as ester |
| 08/13/2002 | US6432396 Sterilization, medical devices, bactericide, fungicide, viricide: palladium or platinum complex having methine or imine group reacted with vinyl polymers, polyurethanes, or polyolefins; thermally induced phase separation membrane of |
| 08/13/2002 | US6432389 High SPF nontacky/nongreasy UV-photoprotecting compositions comprising particulates of MMA crosspolymers |
| 08/13/2002 | CA2269947C Covalent polar lipid conjugates for targeting |
| 08/13/2002 | CA2127987C Pharmaceutical bacteriocin compositions |
| 08/13/2002 | CA2101952C Sulfonylurea derivatives, their preparation and their use |
| 08/13/2002 | CA1341383C Further improvements relating to drug delivery systems |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061040A2 Gene delivery formulations and methods for treatment of ischemic conditions |
| 08/08/2002 | WO2002060978A1 Branched polyalkylene glycols |
| 08/08/2002 | WO2002060955A2 Modified antibodies and methods of use |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060856A1 Novel quaternary ammonium salt compounds, process for producing the same and use thereof |
| 08/08/2002 | WO2002060532A1 Medicament compositions with negligible side-effects containing betamimetics |
| 08/08/2002 | WO2002060501A2 Hydrogel wound dressing,preparation and use thereof |
| 08/08/2002 | WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 08/08/2002 | WO2002060488A1 Anti-tumor compounds |
| 08/08/2002 | WO2002060487A1 Process for producing aqueous cellulose derivative dispersion |
| 08/08/2002 | WO2002060475A1 Methods for stabilizing lyophilized blood proteins |
| 08/08/2002 | WO2002060458A2 Compositions and method of tissue superoxygenation |
| 08/08/2002 | WO2002060454A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | WO2002060437A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | WO2002060420A2 Utilization of a claudin-4 ligand and conjugates thereof in the therapy and diagnosis of tumors |
| 08/08/2002 | WO2002060418A1 Transdermal therapeutic system for administering non-steroidal antiphlogistic agents containing carboxyl groups, and a method for the production of the same |
| 08/08/2002 | WO2002060417A1 Binding agent which is stable in storage and used for pharmaceutical applications |
| 08/08/2002 | WO2002060416A1 Polypeptide delivery system and method for their preparation |
| 08/08/2002 | WO2002060415A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet |
| 08/08/2002 | WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | WO2002060406A2 Veterinary dermatologic composition |
| 08/08/2002 | WO2002060405A1 Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative |
| 08/08/2002 | WO2002060396A2 Hair follicle neogenesis by injection of follicle progenitor cells |
| 08/08/2002 | WO2002060385A2 Pharmaceutical formulation |
| 08/08/2002 | WO2002060384A2 Pharmaceutical formulation |
| 08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002046241A3 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex |
| 08/08/2002 | WO2002045699A3 Transdermal therapeutic system comprising the active ingredient oxybutynin |
| 08/08/2002 | WO2002030466A3 Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002018432A3 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 08/08/2002 | WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 08/08/2002 | WO2002005851A3 Enhancement of the action of central and peripheral nervous system agents |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2002000194A3 Polymeric micelle compositions |
| 08/08/2002 | WO2002000170A3 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001096528A3 Human tumor necrosis factor delta and epsilon |
| 08/08/2002 | WO2001095944A3 Photocleavable prodrugs for selective drug delivery |
| 08/08/2002 | WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives |
| 08/08/2002 | WO2001091814A3 Polyubiquitin based hydrogel and uses thereof |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001082938A3 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/08/2002 | WO2001064182A9 Improvements in or relating to the delivery of oral drugs |
| 08/08/2002 | WO2001051073A9 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 08/08/2002 | WO2001008636A8 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 08/08/2002 | WO2000074736A9 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| 08/08/2002 | US20020107470 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 08/08/2002 | US20020107420 For use as excipient in pharmaceuticals and food processing; compressibility |
| 08/08/2002 | US20020107389 Compound for use in the treatment of autoimmune diseases |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107330 Drug delivery compositions and medical devices containing block copolymer |
| 08/08/2002 | US20020107291 Clear, injectable formulation of an anesthetic compound |
| 08/08/2002 | US20020107250 Orally deliverable cyclooxygenase-2 inhibitor of low water solubility, for example celecoxib, and a glycol ether, for example diethylene glycol monoethyl ether. |
| 08/08/2002 | US20020107238 Topical antibiotic composition for treatment of eye infection |
| 08/08/2002 | US20020107224 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate |
| 08/08/2002 | US20020107222 Modified polysaccharides for treatment of cancer |
| 08/08/2002 | US20020107200 Aqueous solution of parathyroid hormone, stabilizer such as mannitol, and buffering agent for acidic ph; shelf life |
| 08/08/2002 | US20020106792 Immunoisolation of preferential cells; obtain cells, incubate with n-acetylglucosamine, encapsulate, recover cells |
| 08/08/2002 | US20020106747 Esterified polysaccharide products and beta-lactone ring opened ketene dimer products containing the compositions, and process of making the same |
| 08/08/2002 | US20020106410 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
| 08/08/2002 | US20020106409 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use |
| 08/08/2002 | US20020106406 Crystallizable/non-crystallizable polymer composites |
| 08/08/2002 | US20020106405 Pharmaceutical composition for piperidinoalkanol compounds |
| 08/08/2002 | US20020106403 Dispersible phospholipid stabilized microparticles |
| 08/08/2002 | US20020106402 Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| 08/08/2002 | US20020106395 Sustained release drug delivery devices with prefabricated permeable plugs |
| 08/08/2002 | US20020106386 Use for cosmetic and medicinal purposes |
| 08/08/2002 | US20020106345 Therapeutic compositions and methods |
| 08/08/2002 | US20020106337 Products for topical applications comprising oil bodies |
| 08/08/2002 | US20020106332 Process for preparing powder formulations |
| 08/08/2002 | US20020106330 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/08/2002 | US20020106329 Transdermal dosage form |
| 08/08/2002 | US20020106328 Contrast agents |
| 08/08/2002 | US20020106327 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 08/08/2002 | US20020106324 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 08/08/2002 | US20020106304 Enhancing the anti-microbial activity of a borate-containing compound which comprises adding to the composition an effective amount of a low molecular weight amino alcohol, wherein the amino alcohol has a molecular weight of 60-200 |
| 08/08/2002 | DE10104880A1 Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen A multiparticulate pharmaceutical form comprising at least two differently coated pellet forms |
| 08/08/2002 | DE10104367A1 Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen Betamimetics containing pharmaceutical compositions with fewer side effects |
| 08/08/2002 | CA2766160A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2437350A1 Pharmaceutical formulation |
| 08/08/2002 | CA2436776A1 Hydrogel wound dressing, preparation and use thereof |
| 08/08/2002 | CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | CA2436427A1 Compositions and method of tissue superoxygenation |